New Anti-Infective Products launched | Hikma

Share price: 1914p 24.5p

EN

Home
About
About us

We put better health within reach, every day. We're helping to shape a healthier world that enriches all of our communities.

Visit this section
About
Products
Our products

We develop, manufacture and market a broad range of branded and non-branded generic medicines.

Visit this section
Products
Investors
Investors

Information and tools including share price information, dividends, and the latest reports, results and news.

Visit this section
Investors
Sustainability
Sustainability

We’re committed to operating sustainably and feel a real duty of care towards our customers, shareholders and other stakeholders.

Link to sustainability home
Sustainability
Newsroom
Careers
Careers

We’re a global company, putting better health within reach, every day. Take your next career step with us.

Visit this section
Careers
Contact
Contact us

Find contact details for our offices and locations worldwide.

Visit this section
Contact
Country sites
Back
- Global

Follow us

3 March 2010

Product

New Anti-Infective Products launched

Recently registered products:

Factive 320 mg 5 tablets in Algeria (March 09).
Factive 320 mg 7 tablets in Lebanon (November 09).

Share this page

Hikma

Home
Newsroom
New Anti-Infective Products launched

Useful links

About
Products
Investors
Sustainability
News
Careers
Contact
Our brand
Worldwide
Leadership

Stay in touch

Subscribe to our newsletter

Follow us

© Hikma Pharmaceuticals PLC 2019

Terms of use
Cookie policy
Disclaimer
Privacy policy
Social policy

Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.